Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion

July 14, 2023
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.

from Health and Science https://ift.tt/qSm2xCQ
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.